0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
Piramal Enterprises tanked 15 percent intraday on October 25 after the pharma company approved fresh capital raise of Rs 5,400 crore ($770 million) through a rights issue and preferential allotment of Compulsory Convertible Debentures (CCDs).
Share this article
If you liked this article share it with your friends.they will thank you later